Baird Financial »

Intra Cellular Therapies shares owned by Baird Financial

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Baird Financial from 13F filings

Historical chart of Baird Financial investment in Intra Cellular Therapies

2021202220232024202502M4M20k40k60k
Value ($)Share countHistorical ITCI position of Baird Financial Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Baird Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Baird Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $5.4M 65k 83.52
2024-09-30 $3.5M 48k 73.17
2024-06-30 $2.5M 36k 68.49
2020-06-30 $257k 10k 25.70

More positions owned by Baird Financial

Apple Computer Common (AAPL)
Microsoft Corp Common (MSFT)
J.p. Morgan Chase Common (JPM)
Alphabet Common (GOOG)
Berkshire Hathaway Inc Del Cl Common (BRK.B)
Home Depot Common (HD)
Ishares 1000 Growth Russell Common (IWF)
Progressive Corp Ohio Common (PGR)
Ishares 1000 Value Russell Common (IWD)
Vanguard Taxmanaged Fd Europe Common (VEA)
Meta Platforms Common (META)
Ishares Midcap Russell Common (IWR)
Nvidia Corp Common (NVDA)
Fastenal Common (FAST)
Johnson Johnson Common (JNJ)

View all positions for Baird Financial

Top funds holding Intra Cellular Therapies

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Norges Bank Investment Management
Invesco
venBio Select Advisor
Bellevue Group
State Street Corporation
Franklin Resources
Geode Capital Management
ClearBridge Advisors
Pictet Asset Management Holding SA
Deep Track Capital

View all funds holding Intra Cellular Therapies